The UK National Health Service (NHS) is to trial the blood test from Israel’s OncoHost (see here previously) that predicts how well cancer patients will respond to immunotherapy treatment. Trials will focus on patients with advanced melanoma or non-small cell lung cancer.

https://www.timesofisrael.com/israels-oncohost-uks-nhs-to-study-cancer-patient-responses-to-immunotherapies/